p53/MDM2 signaling pathway in aging, senescence and tumorigenesis

被引：23
作者：
Huang, Youyi [1 ,2 ,3 ]
Che, Xiaofang [1 ,2 ,3 ]
Wang, Peter W. [4 ]
Qu, Xiujuan [1 ,2 ,3 ]
机构：
[1] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang 110001, Liaoning, Peoples R China
[2] China Med Univ, Hosp 1, Prov key Lab Anticanc Drugs & Biotherapy Liaoning, Shenyang 110001, Liaoning, Peoples R China
[3] China Med Univ, Hosp 1, Clin Canc Res Ctr Shenyang, Shenyang 110001, Liaoning, Peoples R China
[4] Oasis Med Res Ctr, Dept Med, Watertown, MA 02472 USA
来源：
SEMINARS IN CANCER BIOLOGY | 2024年 / 101卷
关键词：
p53; MDM2; Aging; Carcinogenesis; Senescence; P53 HETEROZYGOUS MICE; DNA-DAMAGE RESPONSE; TUMOR SUPPRESSION; TRANSGENIC MICE; HIGH-FREQUENCY; MDM2; ONCOGENE; CELL-CYCLE; MAMMARY TUMORIGENESIS; TELOMERE DYSFUNCTION; MDM2-DEFICIENT MICE;
D O I：
10.1016/j.semcancer.2024.05.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A wealth of evidence has emerged that there is an association between aging, senescence and tumorigenesis. Senescence, a biological process by which cells cease to divide and enter a status of permanent cell cycle arrest, contributes to aging and aging-related diseases, including cancer. Aging populations have the higher incidence of cancer due to a lifetime of exposure to cancer-causing agents, reduction of repairing DNA damage, accumulated genetic mutations, and decreased immune system efficiency. Cancer patients undergoing cytotoxic therapies, such as chemotherapy and radiotherapy, accelerate aging. There is growing evidence that p53/MDM2 (murine double minute 2) axis is critically involved in regulation of aging, senescence and oncogenesis. Therefore, in this review, we describe the functions and mechanisms of p53/MDM2-mediated senescence, aging and carcinogenesis. Moreover, we highlight the small molecular inhibitors, natural compounds and PROTACs (proteolysis targeting chimeras) that target p53/MDM2 pathway to influence aging and cancer. Modification of p53/MDM2 could be a potential strategy for treatment of aging, senescence and tumorigenesis.
引用
收藏
页码：44 / 57
页数：14
相关论文
共 206 条
[1]   Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer [J].
Adams, Clare M. ;
Mitra, Ramkrishna ;
Xiao, Youcai ;
Michener, Peter ;
Palazzo, Juan ;
Chao, Allen ;
Gour, Jitendra ;
Cassel, Joel ;
Salvino, Joseph M. ;
Eischen, Christine M. .
CANCER DISCOVERY, 2023, 13 (05) :1210-1229
[2]   Therapeutic Strategies to Activate p53 [J].
Aguilar, Angelo ;
Wang, Shaomeng .
PHARMACEUTICALS, 2023, 16 (01)
[3]   Recent Advances in PROTAC-Based Antiviral Strategies [J].
Ahmad, Haleema ;
Zia, Bushra ;
Husain, Hashir ;
Husain, Afzal .
VACCINES, 2023, 11 (02)
[4]   Advancements in MDM2 inhibition: Clinical and pre-clinical investigations of combination therapeutic regimens [J].
Alaseem, Ali M. .
SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (10)
[5]   Mitochondrial and metabolic dysfunction in ageing and age-related diseases [J].
Amorim, Joao A. ;
Coppotelli, Giuseppe ;
Rolo, Anabela P. ;
Palmeira, Carlos M. ;
Ross, Jaime M. ;
Sinclair, David A. .
NATURE REVIEWS ENDOCRINOLOGY, 2022, 18 (04) :243-258
[6]   The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression [J].
Armata, Heather L. ;
Garlick, David S. ;
Sluss, Hayla K. .
CANCER RESEARCH, 2007, 67 (24) :11696-11703
[7]   HIGH-FREQUENCY DEVELOPMENTAL ABNORMALITIES IN P53-DEFICIENT MICE [J].
ARMSTRONG, JF ;
KAUFMAN, MH ;
HARRISON, DJ ;
CLARKE, AR .
CURRENT BIOLOGY, 1995, 5 (08) :931-936
[8]   Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice [J].
Artandi, SE ;
Chang, S ;
Lee, SL ;
Alson, S ;
Gottlieb, GJ ;
Chin, L ;
DePinho, RA .
NATURE, 2000, 406 (6796) :641-645
[9]   Probing p53 biological functions through the use of genetically engineered mouse models [J].
Attardi, LD ;
Donehower, LA .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 576 (1-2) :4-21
[10]   PROTAC targeted protein degraders: the past is prologue [J].
Bekes, Miklos ;
Langley, David R. ;
Crews, Craig M. .
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (03) :181-200
12345678910